GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Feng Chi Biotech Corp (ROCO:6744) » Definitions » Price-to-Owner-Earnings

Feng Chi Biotech (ROCO:6744) Price-to-Owner-Earnings : 22.50 (As of Jun. 05, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Feng Chi Biotech Price-to-Owner-Earnings?

As of today (2024-06-05), Feng Chi Biotech's share price is NT$21.60. Feng Chi Biotech's Owner Earnings per Share (TTM) ended in Dec. 2023 was NT$0.96. It's Price-to-Owner-Earnings for today is 22.50.


The historical rank and industry rank for Feng Chi Biotech's Price-to-Owner-Earnings or its related term are showing as below:

ROCO:6744' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 9.05   Med: 12.28   Max: 24.53
Current: 23.02

During the past 8 years, the highest Price-to-Owner-Earnings of Feng Chi Biotech was 24.53. The lowest was 9.05. And the median was 12.28.


ROCO:6744's Price-to-Owner-Earnings is ranked better than
62.8% of 164 companies
in the Biotechnology industry
Industry Median: 34.035 vs ROCO:6744: 23.02

As of today (2024-06-05), Feng Chi Biotech's share price is NT$21.60. Feng Chi Biotech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$1.47. Therefore, Feng Chi Biotech's PE Ratio for today is 14.69.

As of today (2024-06-05), Feng Chi Biotech's share price is NT$21.60. Feng Chi Biotech's EPS without NRI for the trailing twelve months (TTM) ended in was NT$1.47. Therefore, Feng Chi Biotech's PE Ratio without NRI for today is 14.69.

During the past 8 years, Feng Chi Biotech's highest PE Ratio without NRI was 37.32. The lowest was 12.07. And the median was 16.22.


Feng Chi Biotech Price-to-Owner-Earnings Historical Data

The historical data trend for Feng Chi Biotech's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Feng Chi Biotech Price-to-Owner-Earnings Chart

Feng Chi Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial - 12.94 12.37 11.40 23.86

Feng Chi Biotech Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.37 - 11.40 - 23.86

Competitive Comparison of Feng Chi Biotech's Price-to-Owner-Earnings

For the Biotechnology subindustry, Feng Chi Biotech's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Feng Chi Biotech's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Feng Chi Biotech's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Feng Chi Biotech's Price-to-Owner-Earnings falls into.



Feng Chi Biotech Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Feng Chi Biotech's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=21.60/0.96
=22.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Feng Chi Biotech  (ROCO:6744) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Feng Chi Biotech Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Feng Chi Biotech's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Feng Chi Biotech (ROCO:6744) Business Description

Traded in Other Exchanges
N/A
Address
No. 5, Shaoxing North Street, 5th Floor-1, Zhongzheng District, Taipei City, TWN, 100
Feng Chi Biotech Corp provide promotion and support for clinical testing and molecular genetic medicine research related technologies. The company's products and services include clinical testing, food testing, newborn screening, prenatal screening, iron stomach, interscience, and colony counting.

Feng Chi Biotech (ROCO:6744) Headlines

No Headlines